rss
Br J Ophthalmol 93:1474-1478 doi:10.1136/bjo.2008.155663
  • Original Article

Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy

Table 3

Early Treatment Diabetic Retinopathy Study visual acuity (VA) scores

Subject (B) SE VA
SE Best-corrected VA BL Day 0 3 weeks 6 weeks 12 weeks 18 weeks 24 weeks 30 weeks 36 weeks VA Δ from BL
Intravitreal pegaptanib sodium
    1 OD 55 64 67 64 64 61 64 64 * 9
    2 OS 83 80 83 86 86 79 84 77 85 2
    3 OD 78 73 83 87 94 84 * * * 6
    4 OD 86 89 88 85 89 90 87 89 90 4
    5 OS 71 76 83 78 84 84 81 87 84 13
    6 OD 68 77 72 76 * 85 88 88 83 15
    7 OS 87 83 91 91 87 88 85 84 86 −1
    8 OD 68 72 81 77 84 84 79 79 79 11
    9 OS 77 77 81 78 72 63 44 59 59 −18
    10 OD 85 88 89 89 87 87 81 58 88 3
Panretinal photocoagulation
    11 OS 61 60 59 66 * 64 64 73 74 13
    12 OD 70 74 76 71 75 75 79 74 76 6
    13 OS 82 78 76 78 74 76 79 68 −14
    14 OS 81 86 82 83 81 82 77 68 68 −13
    15 OD 71 77 69 84 72 88 85 84 85 14
    16 OS 80 87 63 84 83 58 76 83 85 5
    17 OS 79 77 75 81 79 81 83 73 13 −66
    18 OD 82 83 77 83 71 84 83 79 78 −4
    19 OD 78 76 77 78 78 78 76 73 80 −2
    20 OS 68 * * * * * * * * *
  • Bold text: lost to follow-up; not included in analysis. Italic text: bilateral subjects.

  • *Patient did not attend this particular visit.

  • BL, baseline; OD, right eye; OS, left eye; SE, study eye.

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.